SCI Pharmtech Inc (4119) — Capital Reinvestment Ratio
SCI Pharmtech Inc (4119) has a Capital Reinvestment Ratio of 0.39x as of June 2026, meaning it reinvests 0% of its operating cash flow (NT$156.75 Million) in capital expenditures (NT$60.99 Million). Check 4119 tangible net assets ratio to evaluate the tangible quality of the company's equity base.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
SCI Pharmtech Inc Capital Reinvestment Ratio (2002–2025)
This chart tracks SCI Pharmtech Inc's Capital Reinvestment Ratio across 23 annual periods. For the full cash flow conversion analysis, see SCI Pharmtech Inc cash flow conversion.
Annual Capital Reinvestment Ratio for SCI Pharmtech Inc (2002–2025)
Year-by-year Capital Reinvestment Ratio for SCI Pharmtech Inc from 2002 to 2025. See 4119 free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
| Year | Reinvestment Ratio | Operating CF (TWD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 2.77x | NT$220.32 Million | NT$610.00 Million | ▲ +151.7% |
| 2024 | 1.10x | NT$860.52 Million | NT$946.64 Million | ▼ -76.9% |
| 2023 | 4.77x | NT$215.77 Million | NT$1.03 Billion | ▲ +21.2% |
| 2022 | 3.94x | NT$296.56 Million | NT$1.17 Billion | ▲ +42.4% |
| 2021 | 2.77x | NT$280.28 Million | NT$774.98 Million | ▲ +1133.9% |
| 2020 | 0.22x | NT$971.53 Million | NT$217.70 Million | ▼ -13.3% |
| 2019 | 0.26x | NT$791.60 Million | NT$204.49 Million | ▼ -23.6% |
| 2018 | 0.34x | NT$480.18 Million | NT$162.44 Million | ▼ -35.4% |
| 2017 | 0.52x | NT$281.65 Million | NT$147.39 Million | ▲ +48.3% |
| 2016 | 0.35x | NT$502.11 Million | NT$177.20 Million | ▲ +7.6% |
| 2015 | 0.33x | NT$663.24 Million | NT$217.51 Million | ▼ -68.1% |
| 2014 | 1.03x | NT$358.77 Million | NT$369.15 Million | ▼ -68.2% |
| 2013 | 3.24x | NT$238.57 Million | NT$773.01 Million | ▲ +590.6% |
| 2012 | 0.47x | NT$385.57 Million | NT$180.90 Million | ▼ -20.7% |
| 2011 | 0.59x | NT$249.55 Million | NT$147.71 Million | ▼ -31.9% |
| 2010 | 0.87x | NT$218.96 Million | NT$190.34 Million | ▲ +52.1% |
| 2009 | 0.57x | NT$316.96 Million | NT$181.13 Million | ▲ +1.5% |
| 2008 | 0.56x | NT$245.29 Million | NT$138.12 Million | ▼ -43.6% |
| 2007 | 1.00x | NT$167.53 Million | NT$167.21 Million | ▼ -18.9% |
| 2006 | 1.23x | NT$131.62 Million | NT$162.00 Million | ▲ +165.3% |
| 2004 | 0.46x | NT$76.61 Million | NT$35.55 Million | ▼ -4.3% |
| 2003 | 0.48x | NT$206.86 Million | NT$100.29 Million | ▲ +24.4% |
| 2002 | 0.39x | NT$107.12 Million | NT$41.73 Million | — |